Katherine Bach Kalin - 13 Aug 2022 Form 4 Insider Report for SELLAS Life Sciences Group, Inc. (SLS)

Role
Director
Signature
/s/ Katherine Bach Kalin
Issuer symbol
SLS
Transactions as of
13 Aug 2022
Net transactions value
$0
Form type
4
Filing time
16 Aug 2022, 16:08:20 UTC
Previous filing
15 Jun 2021
Next filing
03 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLS Stock Option (Right to Buy) Award $0 +19,000 $0.000000 19,000 13 Aug 2022 Common Stock 19,000 $3.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will fully vest on August 13, 2023.